Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House health claims for foods bill same as Senate FDA reform provision.

This article was originally published in The Tan Sheet

Executive Summary

HEALTH CLAIMS FOR FOODS BILL INTRODUCED BY REP. UPTON on July 22. The Consumers' Nutrition and Health Information Act (HR 2208) contains the same provision for health claims as the Senate FDA reform bill (S 830); the measure would allow manufacturers to make health claims on food labels without going through the FDA preapproval process as long as the claims are based on authoritative statements by federal scientific organizations such as the National Institutes of Health or the Centers for Disease Control & Prevention ("The Tan Sheet" June 23, p. 14). The manufacturer would be required to notify FDA of a proposed claim 120 days before it appeared on the market and submit to the agency an explanation of the basis for the claim.

You may also be interested in...



Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

People In Brief

Perrigo promotes in pricing, planning

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087337

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel